Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Eli Lilly and Company
Stephen R D Johnston; Nadia Harbeck; Roberto Hegg; Masakazu Toi; Miguel Martin; Zhi Min Shao; Qing Yuan Zhang; Jorge Luis Martinez Rodriguez; Mario Campone; Erika Hamilton; Joohyuk Sohn; Valentina Guarneri; Morihito Okada; Frances Boyle; Patrick Neven; Javier Cortés; Jens Huober; Andrew Wardley; Sara M Tolaney; Irfan Cicin; Ian C Smith; Martin Frenzel; Desirée Headley; Ran Wei; Belen San Antonio; Maarten Hulstijn; Joanne Cox; Joyce O'Shaughnessy; Priya Rastogi; monarchE Committee Members and Investigators